Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Summit Therapeutics Cash on Hand 2015-2025 | SMMT

Summit Therapeutics cash on hand from 2015 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Summit Therapeutics cash on hand for the quarter ending September 30, 2025 was $0.239B, a 50.97% decline year-over-year.
  • Summit Therapeutics cash on hand for 2024 was $0.413B, a 121.58% increase from 2023.
  • Summit Therapeutics cash on hand for 2023 was $0.186B, a 71.29% decline from 2022.
  • Summit Therapeutics cash on hand for 2022 was $0.649B, a 803.47% increase from 2021.
Summit Therapeutics Annual Cash on Hand
(Millions of US $)
2024 $413
2023 $186
2022 $649
2021 $72
2020 $66
2019 $64
2019 $36
2018 $26
2017 $38
2016 $25
2015 $18
2014 $18
2014
Summit Therapeutics Quarterly Cash on Hand
(Millions of US $)
2025-09-30 $239
2025-06-30 $298
2025-03-31 $362
2024-12-31 $413
2024-09-30 $487
2024-06-30 $326
2024-03-31 $157
2023-12-31 $186
2023-09-30 $199
2023-06-30 $215
2023-03-31 $242
2022-12-31 $649
2022-09-30 $122
2022-06-30 $57
2022-03-31 $77
2021-12-31 $72
2021-09-30 $80
2021-06-30 $103
2021-03-31 $102
2020-12-31 $66
2020-09-30 $21
2020-06-30
2020-03-31 $57
2019-12-31 $64
2019-10-31 $17
2019-09-30
2019-07-31 $26
2019-04-30 $37
2019-01-31
2018-10-31 $17
2018-07-31 $23
2018-04-30 $38
2018-01-31 $26
2017-10-31 $42
2017-07-31 $37
2017-04-30 $25
2017-01-31 $38
2016-10-31 $42
2016-07-31 $9
2016-04-30 $15
2016-01-31 $25
2015-10-31 $34
2015-07-31 $41
2015-04-30 $45
2015-03-31
2015-01-31 $18
2014-12-31 $18
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $14.521B $0.001B
Summit Therapeutics PLC is engaged in the discovery and development of drug to treat the fatal muscle wasting disease Duchenne Muscular Dystrophy and infections caused by the bacteria C. difficile. Summit Therapeutics PLC is headquartered in Abingdon, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $83.859B 31.85
Zoetis (ZTS) United States $53.434B 19.12
Takeda Pharmaceutical (TAK) Japan $44.834B 9.15
Daiichi Sankyo, - (DSNKY) Japan $42.623B 21.23
BeOne Medicines - (ONC) Switzerland $41.395B 219.46
Sandoz Group AG (SDZNY) Switzerland $30.417B 0.00
United Therapeutics (UTHR) United States $19.872B 17.49
Merck (MKKGY) Germany $17.383B 11.30
Shionogi (SGIOY) Japan $14.751B 13.55
Neurocrine Biosciences (NBIX) United States $14.642B 35.13
IPSEN (IPSEY) France $12.599B 0.00
Madrigal Pharmaceuticals (MDGL) United States $12.013B 0.00
Ionis Pharmaceuticals (IONS) United States $11.771B 0.00
Orion OYJ (ORINY) Finland $9.625B 27.50
Eisai (ESAIY) $8.295B 0.00
Corcept Therapeutics (CORT) United States $8.246B 89.08
Stevanato Group S.p.A (STVN) Italy $7.171B 40.14
Grifols, S.A (GRFS) Spain $5.975B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.204B 15.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.586B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.315B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.063B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.738B 17.76
Centessa Pharmaceuticals (CNTA) United Kingdom $3.575B 0.00
Hypermarcas (HYPMY) Brazil $3.161B 21.70
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.800B 8.93
Dyne Therapeutics (DYN) United States $2.658B 0.00
Soleno Therapeutics (SLNO) United States $2.564B 0.00
Ocular Therapeutix (OCUL) United States $2.448B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.049B 24.28
Guardian Pharmacy Services (GRDN) United States $1.998B 38.48
Avadel Pharmaceuticals (AVDL) Ireland $1.859B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.512B 89.75
Collegium Pharmaceutical (COLL) United States $1.497B 7.41
Ardelyx (ARDX) United States $1.468B 0.00
Harrow (HROW) United States $1.424B 87.36
Amylyx Pharmaceuticals (AMLX) United States $1.354B 0.00
Xeris Biopharma Holdings (XERS) United States $1.259B 0.00
Enliven Therapeutics (ELVN) United States $1.202B 0.00
Oruka Therapeutics (ORKA) United States $1.176B 0.00
Nektar Therapeutics (NKTR) United States $1.173B 0.00
Evotec AG (EVO) Germany $1.115B 0.00
Relay Therapeutics (RLAY) United States $1.069B 0.00
Xencor (XNCR) United States $1.028B 0.00
Cronos Group (CRON) Canada $0.973B 0.00
Theravance Biopharma (TBPH) United States $0.895B 37.83
ARS Pharmaceuticals (SPRY) United States $0.884B 0.00
Organogenesis (ORGO) United States $0.822B 0.00
ProKidney (PROK) United States $0.789B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.725B 6.47
Esperion Therapeutics (ESPR) United States $0.724B 0.00
Elite Pharmaceuticals (ELTP) United States $0.717B 0.00
Savara (SVRA) United States $0.712B 0.00
Aquestive Therapeutics (AQST) United States $0.681B 0.00
KalVista Pharmaceuticals (KALV) United States $0.674B 0.00
Bioventus (BVS) United States $0.632B 12.97
4D Molecular Therapeutics (FDMT) United States $0.627B 0.00
Zevra Therapeutics (ZVRA) United States $0.529B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.505B 11.96
Lexeo Therapeutics (LXEO) United States $0.497B 0.00
Akebia Therapeutics (AKBA) United States $0.491B 0.00
Siga Technologies (SIGA) United States $0.445B 6.09
Altimmune (ALT) United States $0.441B 0.00
Galectin Therapeutics (GALT) United States $0.376B 0.00
Nature's Sunshine Products (NATR) United States $0.362B 21.55
USANA Health Sciences (USNA) United States $0.354B 9.89
Lyell Immunopharma (LYEL) United States $0.339B 0.00
Aldeyra Therapeutics (ALDX) United States $0.319B 0.00
Korro Bio (KRRO) United States $0.295B 0.00
Larimar Therapeutics (LRMR) United States $0.279B 0.00
Pyxis Oncology (PYXS) United States $0.272B 0.00
Aclaris Therapeutics (ACRS) United States $0.261B 0.00
Achieve Life Sciences (ACHV) Canada $0.251B 0.00
Journey Medical (DERM) United States $0.239B 0.00
AleAnna (ANNA) United States $0.230B 0.00
OmniAb (OABI) United States $0.226B 0.00
Protara Therapeutics (TARA) United States $0.205B 0.00
Heron Therapeutics (HRTX) United States $0.204B 0.00
Avalo Therapeutics (AVTX) United States $0.203B 0.00
MediWound (MDWD) Israel $0.202B 0.00
Profound Medical (PROF) Canada $0.195B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
Cassava Sciences (SAVA) United States $0.157B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.155B 0.00
China SXT Pharmaceuticals (SXTC) China $0.153B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.137B 0.00
Relmada Therapeutics (RLMD) United States $0.130B 0.00
Incannex Healthcare (IXHL) Australia $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.121B 0.00
Avita Medical (RCEL) United States $0.115B 0.00
Surrozen (SRZN) United States $0.111B 0.00
Context Therapeutics (CNTX) United States $0.108B 0.00
Gain Therapeutics (GANX) United States $0.107B 0.00
Cardiol Therapeutics (CRDL) Canada $0.103B 0.00
Vivani Medical (VANI) United States $0.097B 0.00
Karyopharm Therapeutics (KPTI) United States $0.095B 0.00
Champions Oncology (CSBR) United States $0.095B 34.35
Unicycive Therapeutics (UNCY) United States $0.091B 0.00
Dominari Holdings (DOMH) United States $0.087B 0.00
VAXART, INC (VXRT) United States $0.087B 0.00
Assertio Holdings (ASRT) United States $0.083B 0.00
Prelude Therapeutics (PRLD) United States $0.083B 0.00
Plus Therapeutics (PSTV) United States $0.077B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Acrivon Therapeutics (ACRV) United States $0.072B 0.00
Lite Strategy (LITS) United States $0.072B 0.00
Nutriband (NTRB) United States $0.071B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Talphera (TLPH) United States $0.060B 0.00
BioNxt Solutions (BNXTF) Canada $0.060B 0.00
PolyPid (PYPD) Israel $0.060B 0.00
Fractyl Health (GUTS) United States $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Wellgistics Health (WGRX) United States $0.051B 0.00
Arch Biopartners (ACHFF) Canada $0.050B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
ElectroCore (ECOR) United States $0.048B 0.00
Jupiter Neurosciences (JUNS) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
Tempest Therapeutics (TPST) United States $0.039B 0.00
Inotiv (NOTV) United States $0.038B 0.00
FibroGen (FGEN) United States $0.037B 0.00
Klotho Neurosciences (KLTO) United States $0.036B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.036B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.032B 26.75
Liminatus Pharma (LIMN) United States $0.032B 0.00
Iterum Therapeutics (ITRM) Ireland $0.029B 0.00
Cosmos Health (COSM) United States $0.026B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
Vyome Holdings (HIND) United States $0.019B 0.00
TherapeuticsMD (TXMD) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
Mangoceuticals (MGRX) United States $0.019B 0.00
Heatwurx (PCSA) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.018B 0.00
Natural Alternatives (NAII) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.02
BioLineRx (BLRX) Israel $0.015B 0.00
Ainos (AIMD) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
BioVie (BIVI) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.36
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00